Literature DB >> 26435963

Prediabetes Awareness and Practice Among Indian Doctors- A Cross-sectional Study.

Asha Basavareddy1, Ashwitha Shruti Dass2, Sarala Narayana3.   

Abstract

INTRODUCTION: Prediabetes is an intermediate state between diabetes and normoglycaemia, where the glucose levels are higher than normal but not significant to be diagnosed as diabetes mellitus. Guidelines from various associations suggest different types of management in this situation.
OBJECTIVE: To assess knowledge and attitude of the doctors regarding prediabetes using questionnaire.
MATERIALS AND METHODS: A cross-sectional questionnaire based study was conducted to assess the knowledge, attitude and practice among doctors regarding prediabetes treatment. One hundred twenty two (of 150) filled questionnaires were received from general practitioners, post graduates (PGs), physicians and super specialists in and around Kolar and Bangalore. Data was analysed using descriptive statistics and expressed as percentage.
RESULTS: A total of 81.3% responded to the questionnaire, of which 14 were general practitioners (MBBS), 48 PGs in General Medicine, 46 physicians (MD General Medicine), and 14 super specialists (DM). Knowledge response was 85.7% (definition - 100%, prevalence - 50.8%, approved drug- 45.2%, progression- 86.2%). Screening for prediabetes was done by 71% of the general practitioners and physicians, but specialists would screen all. 100% general practitioners, 97.9% post graduates, 91.3% of physicians and 64.2 % specialist preferred diet and exercise and rest of them opted for oral antidiabetic drug (OAD) along with diet and exercise, but none of the doctors considered OAD alone for prediabetes. Among OADs metformin (77.45%) was the most preferred followed by voglibose (20.6%) and sitagliptin (1.9%).
CONCLUSION: All doctors had awareness of prediabetes and most of them would regularly screen and treat prediabetes. Majority considered diet and exercise as first modality of treatment. The OAD opted commonly was metformin.

Entities:  

Keywords:  Metformin; Normoglycaemia; Voglibose

Year:  2015        PMID: 26435963      PMCID: PMC4576555          DOI: 10.7860/JCDR/2015/13391.6290

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  13 in total

1.  Standards of medical care in diabetes--2011.

Authors: 
Journal:  Diabetes Care       Date:  2011-01       Impact factor: 19.112

2.  The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1).

Authors:  A Ramachandran; C Snehalatha; S Mary; B Mukesh; A D Bhaskar; V Vijay
Journal:  Diabetologia       Date:  2006-01-04       Impact factor: 10.122

3.  Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions.

Authors:  Robert E Ratner; Costas A Christophi; Boyd E Metzger; Dana Dabelea; Peter H Bennett; Xavier Pi-Sunyer; Sarah Fowler; Steven E Kahn
Journal:  J Clin Endocrinol Metab       Date:  2008-09-30       Impact factor: 5.958

4.  International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2009-06-05       Impact factor: 17.152

5.  Role of voglibose in the treatment of prediabetes in Indian population: a cross-speciality survey.

Authors:  Pavitra Raj Dewda; Sourabh Agrawal
Journal:  J Clin Diagn Res       Date:  2013-10-05

6.  Prediabetes: a position statement from the Australian Diabetes Society and Australian Diabetes Educators Association.

Authors:  Stephen M Twigg; Maarten C Kamp; Timothy M Davis; Elizabeth K Neylon; Jeffrey R Flack
Journal:  Med J Aust       Date:  2007-05-07       Impact factor: 7.738

7.  Voglibose for prevention of type 2 diabetes mellitus: a randomised, double-blind trial in Japanese individuals with impaired glucose tolerance.

Authors:  Ryuzo Kawamori; Naoko Tajima; Yasuhiko Iwamoto; Atsunori Kashiwagi; Kazuaki Shimamoto; Kohei Kaku
Journal:  Lancet       Date:  2009-04-22       Impact factor: 79.321

8.  Prediabetes and lifestyle modification: time to prevent a preventable disease.

Authors:  Phillip Tuso
Journal:  Perm J       Date:  2014

9.  Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.

Authors:  Jean-Louis Chiasson; Robert G Josse; Ramon Gomis; Markolf Hanefeld; Avraham Karasik; Markku Laakso
Journal:  Lancet       Date:  2002-06-15       Impact factor: 79.321

10.  Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women.

Authors:  Thomas A Buchanan; Anny H Xiang; Ruth K Peters; Siri L Kjos; Aura Marroquin; Jose Goico; Cesar Ochoa; Sylvia Tan; Kathleen Berkowitz; Howard N Hodis; Stanley P Azen
Journal:  Diabetes       Date:  2002-09       Impact factor: 9.461

View more
  1 in total

1.  Prediabetes awareness among Southeastern European physicians.

Authors:  Visnja Kokic; Slaven Kokic; Mladen Krnic; Marin Petric; Ana Marija Liberati; Petra Simac; Tatjana Milenkovic; Vesna Capkun; Dario Rahelic; Kristina Blaslov
Journal:  J Diabetes Investig       Date:  2017-08-29       Impact factor: 4.232

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.